Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

494.42
-2.8500-0.57%
Volume:188.58K
Turnover:93.53M
Market Cap:21.21B
PE:17.69
High:499.23
Open:498.07
Low:492.57
Close:497.27
52wk High:609.35
52wk Low:402.50
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.31
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.31
PE(LYR):17.75

Loading ...

Jun 16, 2021

Major Issues Report

8-K - Current report
Jun 07, 2021

Major Issues Report

8-K - Current report
Jun 03, 2021

Major Issues Report

8-K - Current report
May 05, 2021

Major Issues Report

8-K - Current report
May 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 19, 2021

Major Issues Report

8-K - Current report
Apr 01, 2021

Major Issues Report

8-K - Current report
Mar 03, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 24, 2021

Major Issues Report

8-K - Current report
Feb 24, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Major Issues Report

8-K - Current report
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Major Issues Report

8-K - Current report
Feb 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 28, 2021

Major Issues Report

8-K - Current report